Implications of comorbidities in nonalcoholic fatty liver disease

키워드

참고문헌 (32)

1. Yip TC, "Geographical similarity and differences in the burden and genetic predisposition of NAFLD", Hepatology (2022)[DOI]
2. Lin H, "Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease", Hepatology, 77, pp.573~584 (2023)
3. Richie Manikat, "Nonalcoholic fatty liver disease and non-liver comorbidities", Clinical and Molecular Hepatology, 29, pp.86~102 (2023), 대한간학회
4. Mantovani A, "Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers : a meta-analysis of observational cohort studies", Gut, 71, pp.778~788 (2022)
5. Targher G, "NAFLD and increased risk of cardiovascular disease : clinical associations, pathophysiological mechanisms and pharmacological implications", Gut, 69, pp.1691~1705 (2020)
6. Lloyd-Jones D, "Heart disease and stroke statistics--2010 update: a report from the American Heart Association", Circulation, 121, pp.e46~e215 (2010)
7. Hill AB, "The environment and disease : Association or causation?", Proc R Soc Med, 58, pp.295~300 (1965)
8. Wong VW, "Noninvasive biomarkers in NAFLD and NASH-current progress and future promise", Nat Rev Gastroenterol Hepatol, 15, pp.461~478 (2018)
9. Younossi ZM, "The global epidemiology of NAFLD and NASH in patients with type 2 diabetes : A systematic review and meta-analysis", J Hepatol, 71, pp.793~801 (2019)
10. Lee HW, "Serial transient elastography examinations to monitor patients with type 2 diabetes : A prospective cohort study", Hepatology, 72, pp.1230~1241 (2020)
11. Mantovani A, "Non-alcoholic fatty liver disease and risk of incident diabetes mellitus : an updated meta-analysis of 501 022 adult individuals", Gut, 70, pp.962~969 (2021)
12. Zhang X, "Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease", Hepatology, 76, pp.1409~1422 (2022)
13. Targher G, "The complex link between NAFLD and type 2 diabetes mellitus-mechanisms and treatments", Nat Rev Gastroenterol Hepatol, 18, pp.599~612 (2021)
14. Ajmera V, "A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes", J Hepatol, 78, pp.471~478 (2023)
15. Zhang H, "Nonalcoholic fatty liver disease, sleep behaviors, and incident type 2 diabetes", J Gastroenterol Hepatol, 37, pp.1633~1640 (2022)
16. Chung SM, "Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus : A 15-year community-based prospective cohort study", Diabetes Res Clin Pract, 184, pp.109208~ (2022)
17. Mesarwi OA, "Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease", Am J Respir Crit Care Med, 199, pp.830~841 (2019)
18. Pamidi S, "Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial", Am J Respir Crit Care Med, 192, pp.96~105 (2015)
19. Iiyori N, "Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity", Am J Respir Crit Care Med, 175, pp.851~857 (2007)
20. Trzepizur W, "Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities", Eur Respir J, 51, pp.1800601~ (2018)
21. Chen LD, "Effect of continuous positive airway pressure on liver enzymes in obstructive sleep apnea : A meta-analysis", Clin Respir J, 12, pp.373~381 (2018)
22. Parikh MP, "Obstructive sleep apnea and the liver", Clin Liver Dis, 23, pp.363~382 (2019)
23. Mahfood Haddad T, "Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events : A systematic review and meta-analysis", Diabetes Metab Syndr, 11(Suppl 1), pp.S209~S216 (2017)
24. Lee SB, "Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis : An observational cohort study", J Hepatol, 68, pp.1018~1024 (2018)
25. Adams LA, "Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases", Gut, 66, pp.1138~1153 (2017)
26. Kasper P, "NAFLD and cardiovascular diseases : a clinical review", Clin Res Cardiol, 110, pp.921~937 (2021)
27. Després JP, "Body fat distribution and risk of cardiovascular disease : an update", Circulation, 126, pp.1301~1313 (2012)
28. Ren Z, "Relationship between NAFLD and coronary artery disease : A Mendelian randomization study", Hepatology, 77, pp.230~238 (2023)
29. Peng H, "Nonalcoholic fatty liver disease and cardiovascular diseases : A Mendelian randomization study", Metabolism, 133, pp.155220~ (2022)
30. Wu M, "Non-alcoholic fatty liver disease and stroke : A Mendelian randomization study", Eur J Neurol, 29, pp.1534~1537 (2022)
31. Xie J, "The associations between modifiable risk factors and nonalcoholic fatty liver disease : A comprehensive Mendelian randomization study", Hepatology, 77, pp.949~964 (2023)
32. Wong VW, "Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1 : Definition, risk factors and assessment", J Gastroenterol Hepatol, 33, pp.70~85 (2018)

관련 논문AI추천